Exxon is a cycle-and-capital-return name: upstream volumes, refining, and a dividend/buyback machine tied to the oil tape. Value/GARP seats belong here; ARK-style trend seats should say so if they pass.
Neff/Graham cash-flow cheapness vs. Templeton/Dalio commodity cycle. Debate: stranded-asset vs. energy-security premium.
Oil and gas price, capex discipline, and Guyana/Permian concentration. Do not apply a software growth screen to a supermajor.
Independent briefs, then clerk assembly · 3 isolated prompts + 1 assembly pass · filing facts from SEC EDGAR (cached 7 days) — not investment advice, no buy button
Preview seating. Paid desks are 16 / 29 / 48 / 61. $49 is Associate (29), not 61. Partners is the same 61 with more compute.
Exxon Mobil Corporation · 10-Q Q2 · FY2026 · ended 2026-06-30 · CIK 0002115436
Filings from SEC companyfacts (us-gaap). P/B, P/S from cached price × diluted shares vs filings. P/S uses YTD sales (interim — not annualized). Not a live quote. Not a live quote, not advice, not a buy button. Missing numbers stay blank; P/E shows n/m when diluted EPS ≤ 0.
Same file, different rules. Each brief states a view and why. Briefs are written in isolation so one loud narrative cannot drag the room. The clerk reads them only after they exist. Never “you should buy.” There is no buy button.
Skeptical — the burden of proof is on the bull case. Owner test on XOM: P/E 37.0, P/B 2.67, ROE 7.2%, net income $18.7B.
Question: “Research XOM as a US-listed name.”. Owner earnings lens on XOM. Plain Midwest English, folksy metaphors, long-horizon. Hard rule: Circle of competence: if the business cannot be explained simply, pass. Numbers on file: P/E 37.0; P/B 2.67; ROE 7.2%; net income $18.7B; revenue YoY 22.2%. On file: 10-Q Q2 FY2026 interim; revenue $201.2B YTD; revenue YoY 22.2%; net income $18.7B; ROE 7.2%; P/E 37.0; P/B 2.7; P/S 3.4; price $165.23 cached. A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk. Underwrite frame: Pass for now.
Constructive — the work is worth continuing, not an order. Classify XOM before cheering growth. revenue YoY 22.2%. P/E 37.0.
Question: “Research XOM as a US-listed name.”. Classify before multiple. Six-category company classification system.. revenue YoY 22.2%. P/E 37.0. revenue $201.2B YTD. On file: 10-Q Q2 FY2026 interim; revenue $201.2B YTD; revenue YoY 22.2%; net income $18.7B; ROE 7.2%; P/E 37.0; P/B 2.7; P/S 3.4; price $165.23 cached. Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay. Underwrite frame: Worth further homework.
Cautious — the file is open, the bar is not cleared. Invert XOM first. What has to be false for the bull to die?
Question: “Research XOM as a US-listed name.”. Invert XOM. Invert: how would this thesis get killed? List the kill-shots before the romance. On file: 10-Q Q2 FY2026 interim; revenue $201.2B YTD; revenue YoY 22.2%; net income $18.7B; ROE 7.2%; P/E 37.0; P/B 2.7; P/S 3.4; price $165.23 cached. Name what must be true for the bull: earnings quality, leverage (D/E not on file), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job. Underwrite frame: Worth further homework.
Counted from isolated briefs. Ratios are filings or cached model input — not a live quote, not a rating, not a buy button.
| Metric | Value | Note |
|---|---|---|
| P/E | 37.0 | P/B, P/S from cached price × diluted shares vs filings. P/S uses YTD sales (interim — not annualized). Not a live quote. |
| P/B | 2.67 | P/B, P/S from cached price × diluted shares vs filings. P/S uses YTD sales (interim — not annualized). Not a live quote. |
| P/S | 3.44 | — |
| ROE | 7.2% | — |
| LT debt / equity | — | — |
| Revenue (YTD) | $201.2B | — |
| Revenue YoY (interim) | +22.2% | — |
| Net income | $18.7B | — |
| Diluted EPS | $4.47 | — |
Cycle, timing, exit, and quant seats are dark on this plan. A three-seat sample cannot locate the cycle or size a position.
Assembly is a second isolated pass over the briefs. Masters did not read each other. Research simulation — not advice, not a buy button.
Analyst unlocks 16 independent seats (16 isolated prompts + 1 assembly pass).
See AnalystCounted from independent briefs only — not a vote, not a recommendation.
Trend research (Wood, Laffont, and the rest of the era desk) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansCycle desk (Dalio, Marks, Templeton) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansWarren BuffettXOM: screened alone against Moat & Management Final Review.
Peter LynchXOM: screened alone against Ten-Bagger Hunter.
Debate starts only after independent briefs exist. Red team still does not see a shared draft.
Charlie Munger — Debate chair · inversion: the best way to kill this thesis
Warren Buffett — Final review · 10-year hold test
Full transcript, risk list, and sizing stay on higher seats.
Unlock more seatsTiming desk (O’Neil and the tape seats) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansExit desk (Livermore, Darvas, Bogle accountability) is locked on Observer.
Unlocks on Committee or Partners (61). Empty seats stay empty — we do not ghost-fill them.
Compare plansQuant (Thorp Kelly sizing, then the full seven on Committee) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansAgents61 is a research simulation and educational tool. Isolated views, splits, and assembly notes only. Not personalized advice. AI-generated.
